Risedronsäure
type: Q8386
type: ChemicalObject
type: ChemicalSubstance
type: Drug
type: Thing
label: Chlorambucil
label: Kanamycin
label: Bloom-Syndrom-Protein
label: Diazoxid
label: Serotonin
label: Guanosin
label: Tolfenaminsäure
label: Cyclopentanol
label: Rofecoxib
label: Propofol
label: Asparagin
label: Aromatase
label: Langerin
label: Kollagen-Typ 10α1
label: Dehydroepiandrosteron
label: Tafamidis
label: Furfural
label: Chelerythrin
label: Uridin
label: VEGF-C
label: Geraniol
label: Sulfite
label: Saquinavir
label: Nedd8
label: Triclosan
label: 1,6-Hexandiol
label: Biotin
label: Uran
label: Angiotensin II
label: CCL2
label: 3-Aminobenzoesäure
label: Tofacitinib
label: 1,2-Cyclohexandion
label: P-Cymol
label: CXCR4
label: Diflunisal
label: HBG1
label: 2-Phenylethanol
label: CD66b
label: Glukoseabhängiges insulinotropes Peptid
subject: Category:Non-receptor tyrosine kinase inhibitors
subject: Category:Triazolopyridines
subject: Category:Disease-modifying antirheumatic drugs
subject: Category:Cyclopropyl compounds
legal uk: POM @en
hypernym: Drug
index2 label: as salt @en
stdinchi: 1
fda unii code: 3XVL385Q0M
smiles: O=CC1CC1 @en
cas number: 1206161-97-8
legal status: Rx-only @en
o: 3
stdinchikey: RIJLVEAXPNLDTC-UHFFFAOYSA-N @en
chemspiderid: 28189566
iupac name: N-cyclopropanecarboxamide @en
verifiedfields: changed @en
atc prefix: L04 @en
c: 21
pubchem: 49831257
h: 23
cas number: 1206161
routes of administration: Oral administration
unii: 3
verifiedrevid: 461425696
display authors: 6
name list style: vanc @en
atc suffix: AF04 @en
chembl: 3301607
drugbank: DB14845 @en
elimination half life: 21600.0
kegg: D10871 @en
kegg: D11106 @en
tradename: Jyseleca @en
ch EMBL: 3301607